拜耳利伐沙班有哪些副作用?
Bayer, has been approved for use in adult patients undergoing hip or knee replacement surgery to prevent venous thrombosis (VTE); and to treat deep vein thrombosis (DVT) in adults to reduce the risk of DVT recurrence and pulmonary embolism (PE) after acute DVT. Atrial fibrillation is a common heart rhythm disorder, with a prevalence of up to 10% in people over the age of 75. The blood of patients with atrial fibrillation is prone to stasis in the atria and the formation of thrombus, and the detachment of the thrombus can lead to stroke. Rivaroxaban, has been approved and recommended for use in adults with non-valvular atrial fibrillation to reduce the risk of stroke and systemic embolism.
Bayer, headquartered in Leverkusen, Germany, has 750 production plants in 200 locations on six continents; it has 120,000 employees and 350 branches in almost every country in the world. Polymers, medicine and health care, chemical industry and agriculture are the company's four pillar industries. The company's product categories exceed 10,000 types. The company has produced aspirin, heroin and other products.
Side effects of Bayer Rivaroxaban (>10%):
Central nervous system: dizziness (2%), insomnia (2%), anxiety (1%), depression (1%), fatigue (1%), syncope (1%)
Dermatology: wound discharge (3%), itching (2%), skin blisters (1%)
Hematology and Oncology: Major bleeding (≤4%)
Neuromuscular and skeletal: back pain (3%), limb pain (2%), muscle spasm (1%)
The above is the relevant content about side effects!
Recommended related hot articles: /newsDetail/93962.html
Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)